Medicine

Medicine

Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in the gambia [measles and rubella vaccine microneedle patch phase 1/2 age de-escalation trial]

HIGHLIGHTS who: Ikechukwu Adigweme from the (UNIVERSITY) have published the research: Study protocol for a phase 1/2, single-centre, double-blind, double-dummy,

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?